Methyl 2-(cyclopentylamino)acetate hydrochloride is a key pharmaceutical intermediate, widely used in the synthesis of various bioactive compounds and drug molecules. It serves as a critical building block for preparing cyclopentylamine-derived pharmaceuticals, especially in the development of anti-inflammatory, analgesic, and central nervous system-related drugs. In organic synthesis, it is employed for introducing cyclopentylamino groups into target molecules via nucleophilic substitution or condensation reactions. Its high purity and stable crystalline form make it suitable for GMP-compliant pharmaceutical production and laboratory-scale synthesis. Additionally, it is utilized in academic research for studying structure-activity relationships of cyclopentyl-containing compounds and in the development of new synthetic methodologies for amino acid derivatives.

GHS Classification: H315 (Causes skin irritation), H319 (Causes serious eye irritation), H335 (May cause respiratory irritation). Signal Word: Warning. Acute oral LD50 >2000 mg/kg (low toxicity). Skin contact may cause redness, itching, or mild dermatitis; wear nitrile gloves and protective clothing when handling. Eye contact can lead to severe irritation and conjunctivitis; use splash-proof goggles and rinse eyes with plenty of water for at least 15 minutes if exposed. Inhalation of dust may irritate the respiratory tract, causing cough or shortness of breath; use in a fume hood or well-ventilated area and wear a dust mask. No evidence of carcinogenicity, mutagenicity, or reproductive toxicity. Harmful to aquatic life; prevent discharge into waterways. Store separately from strong oxidants and acids; neutralize spills with inert absorbent material and dispose of according to local hazardous waste regulations.